Articles

Pfizer pulls plug on push to buy AstraZeneca

Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.

Read More

Finish Line’s chain of running stores ‘turning a corner’

The Finish Line Inc.’s 48-store specialty running chain has been stuck in neutral and unable to grind out a profit since its inception three years ago. But the Indianapolis-based athletics retailer thinks its Running Specialty Group is poised at least to break even this year after reporting small losses every year since 2011.

Read More

Dow Agro parent sets stage for sale or spinoff

Dow AgroSciences LLC is likely to become a stand-alone public company in the next three years, according to some Wall Street analysts—if the wunderkind division of Dow Chemical Co. lives up to sky-high expectations.

Read More